BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10783369)

  • 1. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses.
    Böhlandt S; von Kaisenberg CS; Wewetzer K; Christ B; Nicolaides KH; Brand-Saberi B
    Hum Reprod; 2000 May; 15(5):1155-8. PubMed ID: 10783369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls.
    von Kaisenberg CS; Wilting J; Dörk T; Nicolaides KH; Meinhold-Heerlein I; Hillemanns P; Brand-Saberi B
    Mol Hum Reprod; 2010 Oct; 16(10):778-89. PubMed ID: 20457798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse.
    von Kaisenberg CS; Krenn V; Ludwig M; Nicolaides KH; Brand-Saberi B
    Anat Embryol (Berl); 1998 Feb; 197(2):105-24. PubMed ID: 9497154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency.
    von Kaisenberg CS; Prols F; Nicolaides KH; Maass N; Meinhold-Heerlein I; Brand-Saberi B
    Hum Reprod; 2003 Dec; 18(12):2544-61. PubMed ID: 14645170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses.
    Hyett J; Moscoso G; Nicolaides K
    Am J Med Genet; 1997 Mar; 69(2):207-16. PubMed ID: 9056563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doppler assessment of cardiac function at 11-14 weeks' gestation in fetuses with normal and increased nuchal translucency.
    Huggon IC; Turan O; Allan LD
    Ultrasound Obstet Gynecol; 2004 Sep; 24(4):390-8. PubMed ID: 15343592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
    Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
    BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal nuchal cystic hygromata: associated malformations and chromosomal defects.
    Azar GB; Snijders RJ; Gosden C; Nicolaides KH
    Fetal Diagn Ther; 1991; 6(1-2):46-57. PubMed ID: 1768346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema.
    Bekker MN; van den Akker NM; de Mooij YM; Bartelings MM; van Vugt JM; Gittenberger-de Groot AC
    Reprod Sci; 2008 Apr; 15(3):295-304. PubMed ID: 18421024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal heart rate in chromosomally abnormal fetuses.
    Liao AW; Snijders R; Geerts L; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2000 Dec; 16(7):610-3. PubMed ID: 11169365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.